China’s Health Security Administration said on Sunday that talks to include Pfizer’s Paxlovid in the latest drug list for basic state health insurance did not succeed.
China’s Health Security Administration said on Sunday that talks to include Pfizer’s Paxlovid in the latest drug list for basic state health insurance did not succeed.